MEDIPOST Current Valuation vs. Total Debt

078160 Stock  KRW 12,350  380.00  3.17%   
Based on MEDIPOST's profitability indicators, MEDIPOST Co may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess MEDIPOST's ability to earn profits and add value for shareholders.
For MEDIPOST profitability analysis, we use financial ratios and fundamental drivers that measure the ability of MEDIPOST to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well MEDIPOST Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between MEDIPOST's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of MEDIPOST Co over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between MEDIPOST's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIPOST is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIPOST's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

MEDIPOST Total Debt vs. Current Valuation Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining MEDIPOST's current stock value. Our valuation model uses many indicators to compare MEDIPOST value to that of its competitors to determine the firm's financial worth.
MEDIPOST Co is rated fourth in current valuation category among its peers. It is rated fifth in total debt category among its peers . The ratio of Current Valuation to Total Debt for MEDIPOST Co is about  368.53 . Comparative valuation analysis is a catch-all model that can be used if you cannot value MEDIPOST by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for MEDIPOST's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

MEDIPOST Current Valuation vs. Competition

MEDIPOST Co is rated fourth in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 3.48 Trillion. MEDIPOST retains roughly 453 Billion in current valuation claiming about 13% of equities under Health Care industry.

MEDIPOST Total Debt vs. Current Valuation

Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

MEDIPOST

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
453 B
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

MEDIPOST

Total Debt

 = 

Bonds

+

Notes

 = 
1.23 B
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.

MEDIPOST Total Debt vs Competition

MEDIPOST Co is rated fifth in total debt category among its peers. Total debt of Health Care industry is presently estimated at about 188.58 Billion. MEDIPOST maintains roughly 1.23 Billion in total debt contributing less than 1% to equities under Health Care industry.
Total debt  Capitalization  Workforce  Revenue  Valuation

MEDIPOST Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in MEDIPOST, profitability is also one of the essential criteria for including it into their portfolios because, without profit, MEDIPOST will eventually generate negative long term returns. The profitability progress is the general direction of MEDIPOST's change in net profit over the period of time. It can combine multiple indicators of MEDIPOST, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
MEDIPOST Co., Ltd. provides stem cell therapeutic solutions to meet the unmet medical needs in South Korea and internationally. MEDIPOST Co., Ltd. was founded in 2000 and is headquartered in Seongnam, South Korea. MEDIPOST is traded on Korean Securities Dealers Automated Quotations in South Korea.

MEDIPOST Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on MEDIPOST. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of MEDIPOST position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the MEDIPOST's important profitability drivers and their relationship over time.

Use MEDIPOST in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MEDIPOST position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MEDIPOST will appreciate offsetting losses from the drop in the long position's value.

MEDIPOST Pair Trading

MEDIPOST Co Pair Trading Analysis

The ability to find closely correlated positions to MEDIPOST could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MEDIPOST when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MEDIPOST - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MEDIPOST Co to buy it.
The correlation of MEDIPOST is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MEDIPOST moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MEDIPOST moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MEDIPOST can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your MEDIPOST position

In addition to having MEDIPOST in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Junk Bonds Funds Thematic Idea Now

Junk Bonds Funds
Junk Bonds Funds Theme
Funds or Etfs that invest most of their assets into speculative (junk) bonds or to other fixed income instruments with interest rates 3 to 4 percentage points above government issues. The Junk Bonds Funds theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Junk Bonds Funds Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in MEDIPOST Stock

To fully project MEDIPOST's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of MEDIPOST at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include MEDIPOST's income statement, its balance sheet, and the statement of cash flows.
Potential MEDIPOST investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although MEDIPOST investors may work on each financial statement separately, they are all related. The changes in MEDIPOST's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on MEDIPOST's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.